EUVIMEDEUVIMED entdecken
Klinische Studie (Phase III)Multizentrische StudieRandomisierte kontrollierte StudieÄquivalenzstudieOpen Access · CC BY 4.0

Chemoradiotherapy and transanal endoscopic surgery versus transanal endoscopic surgery alone in T1N0M0 rectal cancer: a multicenter, randomized, controlled, phase III clinical trial (TAUTEM-T1 study)

Xavier Serra-Aracil, Anna Nonell, Cristina Gener-Jorge, Carles Pericay, Thomas Golda, Esther Kreisler, Eloy Espin-Basany, Anna Pallisera, Jesus Badia-Closa, Beatriz Espina, Nerea Borda-Arrizabalaga, Angel Reina und 10 weitere

International Journal of Colorectal Disease · 23.04.2026 · 41 (1)

DOI: 10.1007/s00384-026-05112-y ↗

Kurz gefasst

Klinische Studie (Phase III) in der Zeitschrift International Journal of Colorectal Disease, online erschienen am 23.04.2026. Verfasst von Xavier Serra-Aracil und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery, Universitat Autònoma de Barcelona, Coloproctology Unit, Parc Tauli University Hospital, Institut d'investigació I Innovació Pa…. Hauptthemen laut MEDLINE: Rectal Neoplasms, Chemoradiotherapy, Transanal Endoscopic Surgery. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto de Salud Carlos III, Universitat Autònoma de Barcelona.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

For clinical (c) T1N0M0 rectal adenocarcinoma without adverse pathological features, local excision by transanal endoscopic surgery (TEM) is standard; however, contemporary series still report local recurrence (LR) rates of 15–20%. Preoperative unfavorable histopathologic features cannot reliably identify high-risk pT1 disease, and both completion total mesorectal excision (TME) and salvage TME for LR carry relevant morbidity and functional impairment. Building on our prior phase III trial in T2–T3abN0M0 (TAUTEM study), showing that preoperative chemoradiotherapy (CRT) followed by TEM achieved a 7.4% LR with improved postoperative outcomes, we hypothesize that CRT + TEM will increase rectal preservation in cT1N0M0 without compromising oncologic safety or quality of life. The TAUTEM-T1 trial tests this hypothesis.

Methods

Multicenter, prospective, randomized, controlled, phase III superiority trial. Adults with biopsy-proven rectal low or moderate grade adenocarcinoma ≤ 4 cm, located < 10 cm from the anal verge, staged as cT1N0M0, are randomized (1:1) to: CRT (long-course radiotherapy with concurrent capecitabine) followed by TEM at week 10, or TEM alone. The primary endpoint is rectal preservation at 3 years. Secondary endpoints include postoperative morbidity/mortality, CRT-related adverse events, quality of life and anorectal function, and long-term oncologic outcomes (local/distant recurrence, overall and disease-free survival). Planned sample size: 106 patients.

Results

This manuscript describes the rationale and design of the TAUTEM-T1 randomized trial.

Conclusion

TAUTEM-T1 will assess whether preoperative CRT followed by TEM increases rectal preservation in cT1N0M0 rectal cancer without compromising oncologic safety, quality of life, or bowel function.

Trial registration

ClinicalTrials.gov, NCT06450574.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rectal NeoplasmsChemoradiotherapyTransanal Endoscopic SurgeryHumansNeoplasm StagingQuality of LifeNeoplasm Recurrence, Local

Stichwörter der Autor:innen

Local excision and rectal cancerNeoadjuvant treatment and rectal cancerRectal cancerTotal mesorectal excision (TME)Transanal endoscopic microsurgery (TEM)

Autor:innen und Institutionen

  • Department of Surgery, Universitat Autònoma de Barcelona, Coloproctology Unit, Parc Tauli University Hospital, Institut d'investigació I Innovació Parc Tauli I3PT-CERCA, Sabadell (Barcelona), Spain. javier.serra@uab.cat.
  • Department of Surgery, Universitat Autònoma de Barcelona, Coloproctology Unit, Parc Tauli University Hospital, Institut d'investigació I Innovació Parc Tauli I3PT-CERCA, Sabadell (Barcelona), Spain.
  • Department of Pathology, Universitat Autònoma de Barcelona, Parc Tauli University Hospital, Institut d'investigació I Innovació Parc Tauli I3PT-CERCA, Sabadell (Barcelona), Spain.
  • Medical Oncology Department, Mutua de Terrassa University Hospital, Terrassa (Barcelona), Spain.
  • Colorectal Unit, General and Digestive Surgery Department, Bellvitge University Hospital, Barcelona, Spain.
  • Colorectal Unit, General and Digestive Surgery Department, Vall d'Hebron University Hospital, Departamento de Cirugía, Universitat Autònoma de Barcelona, Barcelona, Spain.

Förderung

  • Instituto de Salud Carlos III
  • Universitat Autònoma de Barcelona

Zitieren

APA

Serra-Aracil, X., Nonell, A., Gener-Jorge, C., Pericay, C., Golda, T., Kreisler, E., Espin-Basany, E., Pallisera, A., Badia-Closa, J., Espina, B., Borda-Arrizabalaga, N., Reina, A., Guadalajara-Labajo, H., Otero, A., Delgado, S., Kraft, M., Querol, R., Flor, B., Pellino, G., …, & TAUTEM-T1 collaborative group (2026). Chemoradiotherapy and transanal endoscopic surgery versus transanal endoscopic surgery alone in T1N0M0 rectal cancer: a multicenter, randomized, controlled, phase III clinical trial (TAUTEM-T1 study). International Journal of Colorectal Disease, 41(1). https://doi.org/10.1007/s00384-026-05112-y

Vancouver

Serra-Aracil X, Nonell A, Gener-Jorge C, Pericay C, Golda T, Kreisler E, et al. Chemoradiotherapy and transanal endoscopic surgery versus transanal endoscopic surgery alone in T1N0M0 rectal cancer: a multicenter, randomized, controlled, phase III clinical trial (TAUTEM-T1 study). International Journal of Colorectal Disease. 2026;41(1). doi:10.1007/s00384-026-05112-y

BibTeX
@article{SerraAracil2026,
  author = {Serra-Aracil, Xavier and Nonell, Anna and Gener-Jorge, Cristina and Pericay, Carles and Golda, Thomas and Kreisler, Esther and Espin-Basany, Eloy and Pallisera, Anna and Badia-Closa, Jesus and Espina, Beatriz and Borda-Arrizabalaga, Nerea and Reina, Angel and Guadalajara-Labajo, Hector and Otero, Ana and Delgado, Salvadora and Kraft, Miquel and Querol, Rosa and Flor, Blas and Pellino, Gianluca and Biondo, Sebastiano and Caro-Tarrago, Aleidis and TAUTEM-T1 collaborative group, TAUTEM-T1 collaborative group},
  title = {Chemoradiotherapy and transanal endoscopic surgery versus transanal endoscopic surgery alone in T1N0M0 rectal cancer: a multicenter, randomized, controlled, phase III clinical trial (TAUTEM-T1 study)},
  journal = {International Journal of Colorectal Disease},
  year = {2026},
  volume = {41},
  number = {1},
  doi = {10.1007/s00384-026-05112-y}
}
Kostenlos starten →